首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Mediterranean journal of rheumatology

缩写:

ISSN:2529-198X

e-ISSN:2529-198X

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引678条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hitesh Verma Hitesh Verma
The present commentary critically evaluates the role of glucosamine in joint health, specifically exploring the potential of vegan glucosamine as an alternative of crustacean glucosamine. While acknowledging glucosamine's established benefi...
Ping Seung Ong,Lay Kim Tan,Hasnah Mat et al. Ping Seung Ong et al.
Objective: The aim of this study was to establish the incidence of liver abnormalities in psoriatic arthritis patients and identify the factors that contributed to this condition. ...
Aryan Mohamadfatih Jalal,Zhala Kakamin Mawlood,Sheelan Faroz Aref et al. Aryan Mohamadfatih Jalal et al.
Objective: The aim of this study was to assess the association between the anthropometric/adiposity indices or ratios with the status of quality of life (QoL) in rheumatoid arthritis (RA) patients. ...
Panagiota Tsatsani,Aspasia Goula,Maria-Aggeliki Stamouli et al. Panagiota Tsatsani et al.
Objectives: To assess the perceptions of patients with rheumatic diseases about the doctor-patient relationship and the impact on their treatment and their quality of life. ...
Shobhit Piplani,Vladimir Jelic,Adejoke Johnson et al. Shobhit Piplani et al.
Aim: The present study aims to investigate the prevalence, causes and outcomes of acute gastrointestinal (GI) bleeding in Rheumatoid arthritis (RA). Metho...
Konstantinos Drougkas,Charalampos Skarlis,Clio Mavragani Konstantinos Drougkas
Type I interferon (IFN) pathway dysregulation plays a crucial role in the pathogenesis of several systemic autoimmune rheumatic diseases (SARDs), including systemic lupus erythematosus (SLE), Sjögren's disease (SjD), systemic sclerosis (SS...
Daniel Martin-Iglesias,Diana Paredes-Ruiz,Guillermo Ruiz-Irastorza Daniel Martin-Iglesias
Glucocorticoids (GCs) are one of the most effective first-line treatments for systemic lupus erythematosus (SLE). However, GC burden is associated with damage. The initial GC dose and tapering schedule should be tailored to the severity of ...
Noemin Kapsala,Dionysis Nikolopoulos,Antonis Fanouriakis Noemin Kapsala
Systemic lupus erythematosus is the prototype multisystem autoimmune disorder characterised by a broad spectrum of organ involvement and a multitude of laboratory abnormalities. Clinical heterogeneity, unpredictable course and lack of patho...
Samuel Díaz-Planellas,Dimitrios Katsifis-Nezis,Antonis Fanouriakis Samuel Díaz-Planellas
Approval of anifrolumab for the treatment of moderate-to-severe systemic lupus erythematosus (SLE) in 2021 marked the success of a long quest to target the interferon system, in a disease wherein the latter has long been considered to play ...